The PI3K/Akt pathway is frequently overexpressed/activated in cancers, and Akt activation promotes a chemoresistant phenotype, whereas Akt inhibition sensitizes chemoresistant cells to cisplatin-induced apoptosis. This evidence concerns the gene AKT1 and cancer.